Literature DB >> 17030216

Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.

Jan M H van den Brande, Maikel P Peppelenbosch, Daan W Hommes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17030216     DOI： 10.1053/j.gastro.2006.08.054

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

1.  Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximab.

Authors:  Alan C Moss; Kyung Jo Kim; Nielsen Fernandez-Becker; Didia Cury; Adam S Cheifetz
Journal:  Dig Dis Sci       Date:  2009-06-18       Impact factor: 3.199

2.  Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase.

Authors:  Sandra Angulo; Albert Morales; Silvio Danese; Laura Llacuna; Maria Carme Masamunt; Nicole Pultz; Maria Grazia Cifone; Claudio De Simone; Salvadora Delgado; Jordi Vila; Julián Panés; Curtis Donskey; Jose C Fernández-Checa; Claudio Fiocchi; Miquel Sans
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

3.  Evaluations and Mechanistic Interrogation of Natural Products Isolated From Paeonia suffruticosa for the Treatment of Inflammatory Bowel Disease.

Authors:  Kun-Chang Wu; Der-Yen Lee; Jeh-Ting Hsu; Chi-Fang Cheng; Joung-Liang Lan; Shao-Chih Chiu; Der-Yang Cho; Jye-Lin Hsu
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

4.  A systematic identification of anti-inflammatory active components derived from Mu Dan Pi and their applications in inflammatory bowel disease.

Authors:  Tzu-Fan Chen; Jeh-Ting Hsu; Kun-Chang Wu; Che-Fang Hsiao; Jou-An Lin; Yun-Hsin Cheng; Yu-Huei Liu; Der-Yen Lee; Hen-Hong Chang; Der-Yang Cho; Jye-Lin Hsu
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.